ArticleFrontiers in oncology2026
Primary intracranial myxopapillary ependymoma: two case reports and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxopapillary ependymoma (MPE), a histological variant of ependymoma, is characterized by a radial arrangement of spindled or epithelioid tumor cells surrounding blood vessels, accompanied by perivascular myxoid changes and microcyst formation. MPE typically occurs in young adults, predominantly in the conus medullaris, cauda equina, and filum terminale. However, primary intracranial MPEs, especially those arising in the cerebral parenchyma, are exceptionally rare. Here, we present two cases of isolated MPEs located in the frontal lobe to underscore their extraordinary rarity. We provide a comprehensive analysis of their clinical characteristics, imaging findings, and pathological features to deepen the understanding and recognition of this rare entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.